Corbus Pharmaceuticals
CRBP
#10362
Rank
ยฃ32.44 M
Marketcap
ยฃ1.57
Share price
-15.40%
Change (1 day)
-82.83%
Change (1 year)

Earnings for Corbus Pharmaceuticals (CRBP)

Earnings in 2026 (TTM): -ยฃ78.3 Million

According to Corbus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ63.32 Million a decrease over its 2024 earnings that were of -ยฃ29.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corbus Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ78.3 Million23.66%
2025 -ยฃ63.32 Million116.04%
2024 -ยฃ29.31 Million-14.54%
2023 -ยฃ34.3 Million28.56%
2022 -ยฃ26.68 Million-37.68%
2021 -ยฃ42.8 Million-54.41%
2020 -ยฃ93.88 Million59.28%
2019 -ยฃ58.95 Million35.87%
2018 -ยฃ43.38 Million74.27%
2017 -ยฃ24.9 Million62.94%
2016 -ยฃ15.28 Million125.82%
2015 -ยฃ6.77 Million251.68%
2014 -ยฃ1.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Viking Therapeutics
VKTX
-ยฃ0.48 Billion 500.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-ยฃ0.14 Billion 70.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
-ยฃ0.15 Billion 75.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-ยฃ26.01 Million-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA